Wang Jia-Kang, Lai Pei-Ching, Liao Shu Lang
Department of Ophthalmology, Far Eastern Memorial Hospital, Taipei, Taiwan.
Am J Ophthalmol. 2009 Jan;147(1):162-170.e1. doi: 10.1016/j.ajo.2008.05.001. Epub 2008 Jun 24.
To investigate the long-term outcome of the Bioceramic orbital implant.
A retrospective, comparative, nonrandomized study.
Data were collected from the patients receiving Bioceramic orbital implants at National Taiwan University Hospital between June 1, 2001 and November 1, 2005. The implant was wrapped with Vicryl mesh, adding anteriorly with a scleral patch graft following enucleation with primary or secondary implantation. The unwrapped implant was inserted into an eviscerated globe with posterior sclerotomy and cornea preserved. Primary or secondary placement of sleeve was performed in some patients.
A total of 112 cases were reviewed. Four patients were excluded attributable to insufficient follow-up. The other 108 patients had a mean follow-up period of 35.8 +/- 10.6 months (range, 24 to 70 months). Fifty patients (46.3%) received the pegging procedure. Eight of 108 (7.4%) cases of late exposure were identified on average 20.7 months after implantation. We identified no cases of implant exposure in 30 cases of enucleation and eight cases of secondary implant when the implant was wrapped in Vicryl mesh and an anterior scleral cap was used. All exposures developed in eviscerated patients (70 cases): two without pegging, three with primary placement, and three with secondary placement of the sleeve. The exposure rate was higher in patients with eviscerated globes, pegged implants, and prior ocular operations (P < .005).
Late exposures of Bioceramic implants were found after long-term follow-up, associated with evisceration, pegging, and prior ocular surgeries. The modified wrapping technique can prevent exposure following secondary implantation and enucleation.
探讨生物陶瓷眼眶植入物的长期效果。
一项回顾性、对比性、非随机研究。
收集2001年6月1日至2005年11月1日在台湾大学附属医院接受生物陶瓷眼眶植入物的患者的数据。植入物用薇乔网包裹,眼球摘除并进行一期或二期植入后,在前方加用巩膜补片移植。未包裹的植入物通过后巩膜切开术插入已摘除眼球的眼内,保留角膜。部分患者进行了一期或二期套管置入。
共回顾了112例病例。4例因随访不足被排除。其他108例患者的平均随访期为35.8±10.6个月(范围24至70个月)。50例(46.3%)接受了栓钉植入手术。108例中有8例(7.4%)发生晚期暴露,平均在植入后20.7个月发现。当植入物用薇乔网包裹并使用前部巩膜帽时,我们在30例眼球摘除病例和8例二期植入病例中未发现植入物暴露的情况。所有暴露均发生在已摘除眼球的患者(70例)中:2例未进行栓钉植入,3例进行了一期套管置入,3例进行了二期套管置入。已摘除眼球患者、植入栓钉的植入物患者和既往有眼部手术史的患者的暴露率较高(P < 0.005)。
经过长期随访发现生物陶瓷植入物存在晚期暴露情况,与眼球摘除、栓钉植入和既往眼部手术有关。改良的包裹技术可防止二期植入和眼球摘除后的暴露。